Lactorel

Pharmacological chaperone indicated as a long-term oral treatment for adolescent and adult patients with a confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) who carry amenable mutations.

Therapeutic Area
Rare Diseases

Active Ingredient
Migalastat

Line
Rare Diseases

Dosage Forms
123 mg x 14 hard capsules.